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Abstract
　This research investigated and reported on whether or not intravenous administration of 
eritadenine to ovariectomized (OVX) rats affects serum lipid parameters like those found in the 
results of studies on its oral administration. Serum triglyceride, phospholipid, and total cholesterol 
levels were significantly lower in the OVX and Sham groups intravenously administered 
eritadenine than in the control OVX and Sham groups. The present results suggest that the 
administration of eritadenine in saline at a rate of 0.5 mg/mL and amount of 1 mL per kg of body 
weight via the tail vein for 10 days decreased serum lipid levels to a similar extent as when it was 
orally administered.
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1. Introduction
　A number of mushrooms have recently been studied for their physiological effects, such as decreasing 
serum lipid concentrations1-4), anti-tumor activity5), the suppression of blood pressure elevations6,7), and the 
inhibition of increases in blood glucose8). The enhancing effects of mushrooms on lipid metabolism have 
been examined in detail. The cholesterol-lowering effects of eritadenine in shiitake mushrooms may be due 
to the strong inhibitory activity of S-adenosyl-L-homocysteine hydrolase (SAHH)9-13). However, these studies 
involved the oral administration of eritadenine and shiitake mushrooms.
　Takashima et al. showed that a single dose of 50 mg / kg eritadenine intravenously has no effect on 
serum cholesterol14). However, as Takashima et al. stated, it can be considered that the maintenance of an 
effective concentration of eritadenine in the target organs for a certain period of time may be necessary for 
the effect to be seen. Therefore, it was thought that if it was administered multiple times rather than in a 
single dose, there is a possibility that the effect may be obtained. Specifically, a 0.5 mg / ml concentration of 
erythadenine was administered 10 times at a rate of 1 ml / kg BW.
　On the other hand, since the reports of serum lipids lowering the action of eritadenine in OVX rats was 
not found, ovariectomized (OVX) rats, which are a model of obesity15-17), were selected for this study.
　We intravenously administered eritadenine for the purpose of confirming its ability to decrease serum 
lipid levels. Since the titer of orally administered eritadenine is considered to be 5 mg/kg BW based on 
previous findings11-13), eritadenine was administered at a dose of at 0.5 mg/kg BW at ten different times in 
the present study.
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2. Materials and Methods
2.1 Animals and diets
　This study was conducted in accordance with the ethical guidelines of the Beppu University Animal 
Experimentation Committee and in complete compliance with the National Institutes of Health Guidelines 
for the Care and Use of Laboratory Animals, and was also approved by this committee18).
　Twenty eight female 4 week-old Sprague-Dawley rats (Japan Clare Co., Japan) were fed a commercial diet 
(MF, Oriental Yeast Co., Tokyo) for one week. After acclimation for one week, rats were randomly divided 
into four groups consisting of seven animals. Two groups underwent OVX surgery and the other two 
groups were subjected to sham surgery. All rats were allowed free access to food and tap water. Rats were 
individually housed in plastic cages kept in a room at a controlled temperature (25 ± 2 ℃) and humidity 
(55 ± 5%). Lights were maintained on a 12-h light-dark cycle (lights on from 7:00 to 19:00). Body weight was 
measured every day. Food intake was recorded every 5 weeks after surgery.
2.2 OVX
　After acclimation for one week, OVX and sham surgery were performed at 5 weeks of age. General 
anesthesia was performed with pentobarbital (somnopentyl, Kyoritsu Pharmaceutical) administered 
intraperitoneally (5.0 mg/100 g body weight), and the area of the back at the peripheral portion of the 
lumbar vertebra was shaved and disinfected with 70% ethanol. The skin was surgically opened at a single 
site to incise the muscles surrounding the kidneys at the left and right sites, and in order to remove the 
ovaries of fat. After uterine ligation with silk thread, the uterus was replaced to the original site. The 
incised muscle layer and skin were disinfected again with 70% ethanol after suturing. In the Sham group, 
the skin was incised and suturing was performed without OVX.
2.3 Administration of eritadenine
　Eritadenine manufactured by Santa Cruz Biotechnology was used in the present study, a solution 
prepared by mixing eritadenine with 0.5 mg/mL saline. One group among the OVX rats was intravenously 
administered the eritadenine solution at a rate of 1mL/kg body weight on the 20th week after surgery, 
while the other group was administered physiological saline. Similarly, one group among the sham-operated 
rats was intravenously administered the eritadenine solution at a rate of 1mL/kg body weight on the 20th 
week after surgery, while the other group was administered physiological saline. The administration period 
was for 10 days in each case.
　In this study, the dose concentration of eritadenine was set at 0.5 mg/mL. In the experiment on the 
influence of eritadenine on serum lipids by oral ingestion, 50 mg of eritadenine was administered per kg of 
diet, and the intake amount for 14 days was 200 g19). Therefore, a total of 10 mg eritadenine was administered 
in 14 days. In addition, prior to this study, eritadenine was administered at a concentration of 0.2 mg/mL 
for 5 days, but there was absolutely no effect on serum lipids. When the administration concentration of 
eritadenine was 0.5 mg/mL and the administration days were 10 days, serum total cholesterol levels were 
decreased. Based on these results it is concluded that the administration concentration of eritadenine was set 
at 0.5 mg/mL and the administration days were set at 10 days in this study.
2.4 Sampling procedures and measurement of serum parameters
　Blood collection (pre-administration: pre) was started on the 20th week after OVX and sham surgery. 
After fasting for 8 hours from 8:00-16:00 (light term), blood was collected from the tail vein (pre-administration: 
pre) under isoflurane anesthesia (Pfizer), and the first administration of eritadenine and physiological saline 
(control groups) was performed. On the next day, after fasting for 8 hours from 8:00-16:00 (light term), 
eritadenine and physiological saline were administered again (10 times in total) under isoflurane anesthesia. 
On the day after the 10th administration of eritadenine and physiological saline, blood was collected under 
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isoflurane anesthesia after fasting for 8 hours from 8:00-16:00 (light term). Rats were euthanized under 
isoflurane anesthesia.
　Blood was centrifuged at 3000 rpm for 10 min. Serum was frozen immediately and stored at -80℃ 
until assayed. Serum triglyceride20), phospholipid21), and total cholesterol22) levels were measured using a 
previously described enzymatic method. Lecithin cholesterol acyl transferase (L-CAT) activity levels were 
assayed using the dipalmitoyl lecithin substrate method23).
2.5 Statistical analysis
　Results were expressed as means ± standard deviation (SD). The significance of differences in body 
weights and food intake between the OVX group and Sham group were analyzed by the Student’s t-test 
for independent samples. The significance of differences in serum parameters between pre and the 10 day 
administration of eritadenine or saline were analyzed by the Student’s paired t-test. A p value of 0.05 or less 
was considered to be significant. Statistical analyses were performed using SPSS Ver16.0 software (SPSS, 
Tokyo, Japan).
3. Results
3.1 Body weight and food intake
　The initial body weights for each group were as follows: OVX (Eritadenine) 176.5 ± 13.6g, OVX (Control) 
174.9 ± 15.2g, Sham (Eritadenine) 178.7 ± 11.3g, and Sham (Control) 175.3 ± 14.0g. Immediately after 
surgery, body weights were higher in the OVX groups than in the Sham groups (Figure 1). After starting 
the administration of the eritadenine or saline, the body weight tended to decrease in all groups. There 
Figure 1　Effects of eritadenine intravenous injections on body weight in ovariectomized (OVX) rats
Eri: intravenous injection of eritadenine, Con: intravenous injection of saline. Values are means ± 
SD. Different letters indicate significant differences between the OVX group and the Sham group 
tested with the Student’s t-test between groups (p<0.05).
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was no significant difference between the eritadenine administration group and control group. In the 5th, 
10th, and 20th weeks after surgery, food intake was significantly higher in the eritadenine-administered 
OVX groups than in the eritadenine-administered Sham groups (Figure 2). However, food intake in all 
groups decreased with time, and no significant differences were observed between the 4 groups on day 5 of 
administration. 
　
3.2 Serum lipid and L-CAT activity levels
　Serum triglyceride levels were significantly lower in the OVX and Sham groups receiving eritadenine for 
10 days (Figure 3a). Serum phospholipid levels were significantly lower in all groups by administration for 
10 days (Figure 3b). The difference was particularly large in the group receiving eritadenine. Serum total 
cholesterol levels were significantly lower in the OVX and Sham groups receiving eritadenine for 10 days 
(Figure 3c). L-CAT activity levels were significantly lower in the OVX group receiving eritadenine for 10 
days (Figure 3d). 
4. Discussion
　This research investigated whether or not intravenously administered eritadenine affects serum lipid 
parameters to a similar extent as in its oral administration. In our study, intravenous administration of 
eritadenine showed lowering lipid effects. 
　Body weight was slightly higher in the OVX group than in the Sham group. Food intake by mice and 
rats has been shown to increase following OVX24). Although no significant differences were observed in the 
present study, food intake slightly increased in the OVX group, which may account for the weight gain 
observed. It was speculated that weight loss on day 5 of administration was due to a decreased food intake 
caused by isoflurane anesthesia or puncture of the tail vein during intravenous administration.
　Serum triglyceride, phospholipid, and total cholesterol levels were significantly lower in the OVX and 
Sham groups treated with eritadenine for 10 days. Serum triglyceride levels were significantly higher in 
Figure 2　Effects of eritadenine intravenous injections on daily food intake in ovariectomized (OVX) rats 
Eri: intravenous injection of eritadenine, Con: intravenous injection of saline. Values are means ± SD. 
*p<0.05, **p<0.01 indicate significant differences between the OVX group and the Sham group tested 
with the Student’s t-test.
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Figure 3　 Effects of eritadenine intravenous injections on serum lipid profiles and lecithin-cholesterol acyltransferase 
(L-CAT) activities in ovariectomized (OVX) rats
Eri: intravenous injection of eritadenine, Con: intravenous injection of saline. Values are means ± SD. *p<0.05, 
**p<0.01, ***p<0.001 indicate significant differences between pre and the administration of eritadenine or saline 
tested with the Student’s paired t-test.
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the Sham groups than in the OVX groups before the administration of eritadenine and saline. However, 
the reason for this remains unclear. L-CAT activity levels were significantly decreased in the eritadenine-
administered OVX group, but were only slightly reduced in the three other groups. Serum triglyceride 
levels and total cholesterol levels were significantly lower in groups treated with eritadenine than in the 
control group. There was no significant difference in total cholesterol elevation due to the OVX operation, 
but total cholesterol was significantly decreased by eritadenine. In the 20 weeks after OVX surgery food 
intake increased, but no significant increase in serum triglyceride or cholesterol was observed, so it seems 
that it is necessary to review the postoperative period and the others as well. For example, it is considered 
that serum total cholesterol increased effectively by adding cholesterol to the diets.
　These results suggest that the administration of eritadenine at a dose of 0.5 mg/kg body weight via 
the tail vein at ten times the previous amount decreased serum lipid levels. The titer of intravenously 
administered eritadenine may be 5 mg/kg BW, which is similar to that of its oral administration in rats11-13,19). 
As we hypothesised, our results showed the lowering lipid effects of eritadenine by intravenous 
administration contrary to Takashima’s report. We think this is because eritadenine was administered 
repeatedly, which might have sustained its serum concentration even at the target organ and showed its 
effect. Intravenous administration is considered to be effective because it is not affected by absorption and a 
scientific term. The repeated administration of eritadenine may have been effective for lowering serum total 
cholesterol levels in the present study.
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